Profitable Ideas for a Turbulent Market
Ideas & Strategies Now… FREE
InvestingChannel.Com’s Ideas & Strategies section is for registered users only.
But don’t worry, Joining is FREE and registration will be the most valuable thirty seconds you’ll spend all day. That’s because our quick sign-up page gives you instant access to useful and original investment content covering options, ETFs, fixed income, currencies and equities of all sizes and risk levels.
- Read actionable options commentary from Jared Woodard of Condor Options.
- Access the ETF, equity, and foreign-exchange genius of Simon Maierhofer of iSpyETF.
- Get the perfect mix of cash flow and technical analysis from the team at Investor Playbook.
…plus more compelling investment research that you can immediately put to great use.
Here are just a few examples of the clear and concise commentary
you’ll find every day within Ideas & Strategies:
3. Speaking of the #Nasdaq — what a mind boggling statistic: almost 40% of Nasdaq stocks are down at least -50% from their respective 52-week highs.Traffic lights are yellow…h/t @sentimentrader $COMPQ $NDX $QQQ pic.twitter.com/hie6bAlzlT— Callum Thomas (@Callum_Thomas) January 8, 2022 The NASDAQ appears to me to be in serious technical trouble. For a while now, I’ve been writing about the “stealth bear market”. That is, important but not leading stocks have been breaking down beneath the surface without doing much... -Top Gun Financial Planning
Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulator compositions In an exclusive interview with The Fly, Axcella (AXLA) CEO Bill Hinshaw talked about the company, its pipeline, long COVID, the NASH opportunity and much more. LONG COVID TRIAL: Axcella and Oxford University have started dosing long COVID patients in their Phase 2a clinical trial investigating AXA1125 as potential treatment for the debilitating symptoms of the disease. "The trial is going very well... -The Fly
Tracking existing home inventory is very important in 2022.Inventory usually declines sharply over the holidays and into January, and this is a new record low for this series.Click on graph for larger image in graph gallery.This inventory graph is courtesy of Altos Research. As of January 14th, inventory was at 284 thousand (7-day average), compared to 389 thousand for the same week a year ago.  That is a decline of 28.6%.  Inventory was down 2.9% from the previous week.  A week ago, inventory was at 292 thousand, and was down... -Calculated Risk
Find out right now what’s new in Ideas & Strategies today.
Click HERE to Register.
When you register, you’ll not only get top-tier original InvestingChannel content, but also InvestingChannel Daily, the free e-letter, delivered directly to your inbox.
Discover today the great ideas reserved for only registered users within InvestingChannel.com’s Ideas & Strategies!